MedTrace Logo

Daily Light Exposure for Sleep Disturbance, Fatigue, and Functional Outcomes in Acute Brain Injury

NCT03125967 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2022-05-09

No results posted yet for this study

Summary

The purpose of this study is to assess the safety and efficacy of daily morning exposure to colored light in patients receiving acute inpatient rehabilitation services for stroke, traumatic brain injury, or non-traumatic brain injury with sleep disturbances such as poor nighttime sleep and/or excessive daytime sleepiness.In a two-arm randomized placebo-controlled study with pre-exposure and post-exposure assessments, we are comparing the effects of daily morning exposure to either blue light or red light on objective sleep quality, subjective sleep quality, functional rehabilitation outcomes, cognitive symptoms, fatigue, and neurological symptoms.

Conditions

Interventions

OTHER

Philips GoLite Blu HF3429/60

Exposure to daily morning colored light in the 440-485 nm wavelength range

OTHER

Philips LivingColor Aura 70998/60/48

Exposure to daily morning colored light in the 625-740 nm wavelength range

Sponsors & Collaborators

  • Washington State University

    collaborator OTHER

  • St. Luke's Rehabilitation Institute

    lead OTHER

Principal Investigators

  • Douglas L Weeks, PhD · St. Luke's Rehabilitation Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03125967 on ClinicalTrials.gov